BJOG An International Journal of Obstetrics & Gynaecology · 2002 · 28 citations · 6 references
MedicineMicrobiologyPathologyCervical DiseaseCytopathologyVirologyCervical BiopsyCervical CancerCervical CytologyCervical Intraepithelial NeoplasiaCervical PathologyHuman Papillomavirus InfectionCase-control Study DesignControlsEradicationHpv PersistenceHuman Papillomavirus StatusNested Case-control DesignPersistent Cervical InfectionPersistent Human Papillomavirus Infection
In a need case-control study, we identified women who were successfully treated for CIN 3. Cases had biopsy proven recurrence, whilst controls remained disease free for at least five years. One hundred and seventy-two women were beta-globin positive at diagnostic and at six-month post-treatment smear (90 controls and 82 cases). Thirty-nine cases (47.6%) were HPV16/18 positive at biopsy or follow up smear and 14 (17.1%) of 82 were positive at both. Of the controls, 37 (41.1%) were HPV positive at biopsy or smear with (3.3%) positive at both. The unadjusted OR associated with being HPV positive at both points compared to being HPV negative at both was 8.0 (95% CI 2.13-30.37). The persistence of HPV 16/18 infection following the confirmed eradication of CIN is a highly significant risk factor for recurrence.
6
Choice Reviews Online · 1990 · 35.7K citations
Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia
W. P. Soutter, Alberto Lopes, Astrid Fletcher et al. · The Lancet · 1997 · 273 citations
Medicine, Gynecology, Oncology +12
Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III
Peter Bistoletti, Agneta Zellbi, J. Moreno‐López et al. · Cancer · 1988 · 29 citations · Full text
Medicine, Gynecology, Pathology +17